Technology
Health
Medical
Aethlon Medical
$0.3749876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.374
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.0238 (6.80%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell AEMD and other stocks, options, ETFs, and crypto commission-free!
About
Aethlon Medical, Inc. Common Stock, also called Aethlon Medical, is a therapeutic technology company, which focuses on addressing global health and biodefense needs. Read More It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.
Employees
6
Headquarters
San Diego, California
Founded
1998
Market Cap
6.95M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
169.16K
High Today
$0.3999
Low Today
$0.3022
Open Price
$0.3502
Volume
125.67K
52 Week High
$1.74
52 Week Low
$0.302
Collections
Technology
Health
Medical
Cancer Prevention
US
North America
News
Yahoo FinanceMay 13
Aethlon Medical Announces Collaboration With Prostate On-Site Project, Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies
Company also announces issuance of European patent covering TAUSOMEâ„¢ technology PHOENIX, May 13, 2019 /PRNewswire/ -- Aethlon Medical Inc. (AEMD) and its diagnostic subsidiary, Exosome Sciences, in collaboration with the Translational Genomics Research Institute (TGen) and the Prostate On-Site Project (POP), announced that Aethlon, TGen and POP will engage with participants for their studies of chronic traumatic encephalopathy (CTE) in living individuals during the 18th annual Jerry Colangelo Sports Legend...
Price Paid on Robinhood
63% Lower
Right Now
52 Week Low
$0.302
Average Price Paid
$1.01
52 Week High
$1.74
Earnings
-$0.14
-$0.09
-$0.05
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Jun 7, After Hours